Related Experiment Video
Updated: Jul 12, 2025

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks
Published on: December 2, 2022
Clinical and mycological implications of cryptococcal meningitis in Iran
Bahareh Bashardoust1,2, Ilad Alavi Darazam3,4,5, Roshanak Daie Ghazvini1
1Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
Cryptococcal meningitis (CM) is an uncommon and severe infection that tends to affect both immunocompromised and immunocompetent hosts. To gain insights into the clinical and epidemiological characteristics of CM in Iran, this study evaluated patients with subacute or chronic meningitis referred to 15 Iranian hospitals. Relevant clinical and epidemiological characteristics of the patients were analyzed. Diagnosis of CM cases was performed by microscopic examination, culture, latex agglutination assay, lateral flow assay, and multiplex PCR on cerebrospinal fluid (CSF) samples. The isolates were processed and subjected to molecular identification and in vitro susceptibility antifungal profile. Among the 272 evaluated patients, 7 (2.6 %) CM cases were diagnosed. Out of seven CM cases, 6 (86 %) were male with a median age of 36 years. The most common neurological signs were headache (100 %), followed by nausea and vomiting (71.4 %). All CSF samples from CM patients exhibited positive results across all mycological tests conducted. The isolates were identified as Cryptococcus neoformans (86 %) and Cryptococcus gattii (14 %). All isolates were susceptible to voriconazole and fluconazole, while resistance was observed with itraconazole (MIC value of 0.5 μg/mL) and amphotericin B (MIC values of 4 and 1 μg/mL). The highest mortality (6/7, 86 %) was observed among patients. While a comprehensive study on this subject is currently lacking in Iran, the data acquired through this research play a crucial role in enhancing the clinical and epidemiological understanding of this infection, particularly within low-income countries. Moreover, these findings will serve as a cornerstone for future international comparative studies in this field.
Insights
Cryptococcal meningitis (CM) is a severe infection. This study in Iran found CM in 2.6% of meningitis cases, with high mortality and specific antifungal resistance patterns.
Area of Science:
- Infectious Diseases
- Mycology
- Epidemiology
Background:
- Cryptococcal meningitis (CM) is a severe central nervous system infection, affecting both immunocompromised and immunocompetent individuals.
- Limited data exists on the clinical and epidemiological profile of CM in Iran, necessitating local research.
Purpose of the Study:
- To investigate the clinical and epidemiological characteristics of cryptococcal meningitis in Iran.
- To analyze the diagnostic methods, causative species, and antifungal susceptibility profiles of Cryptococcus isolates in Iranian patients.
Main Methods:
- A multicenter study evaluated 272 patients with subacute or chronic meningitis across 15 Iranian hospitals.
- Diagnosis involved microscopic examination, culture, latex agglutination, lateral flow assay, and multiplex PCR on cerebrospinal fluid (CSF).
- Molecular identification and in vitro antifungal susceptibility testing were performed on isolated Cryptococcus species.
Main Results:
- Seven cases (2.6%) of CM were diagnosed, predominantly in males (86%) with a median age of 36.
- Headache (100%) and nausea/vomiting (71.4%) were the most common neurological signs.
- Isolates were identified as Cryptococcus neoformans (86%) and Cryptococcus gattii (14%). High mortality (86%) was observed.
Conclusions:
- CM is a rare but severe condition in Iran, characterized by specific clinical presentations and high mortality.
- Observed antifungal resistance to itraconazole and amphotericin B highlights potential treatment challenges.
- This study provides crucial data for understanding CM in Iran and low-income countries, informing future research and clinical management.

